Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Other Financing: S$-4.28 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Singapore Institute Of Advanced Medicine Holdings Other Financing?

Singapore Institute Of Advanced Medicine Holdings SGX:9G2 +3.45% Other Financing is S$-4.28 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

Singapore Institute Of Advanced Medicine Holdings's Other Financing for the three months ended in Mar. 2026 was S$-0.43 Mil.

Singapore Institute Of Advanced Medicine Holdings's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was S$-4.28 Mil.

Singapore Institute Of Advanced Medicine Holdings Other Financing Historical Data

* Premium members only.

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Institute Of Advanced Medicine Holdings Other Financing Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Other Financing
-3.51 -2.71 -3.74 0.43 -1.74

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
Jun21 Jun22 Jun23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only 0.00 -0.85 -3.85 0.00 -0.43

Singapore Institute Of Advanced Medicine Holdings Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was S$-4.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of S$-4.28 Mil mean?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a Other Financing of S$-4.28 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Singapore Institute Of Advanced Medicine Holdings and its competitors.
Is Singapore Institute Of Advanced Medicine Holdings' Other Financing too high?
Singapore Institute Of Advanced Medicine Holdings' current Other Financing is S$-4.28 Mil.
How does Singapore Institute Of Advanced Medicine Holdings' Other Financing compare to HCA and THC?
Singapore Institute Of Advanced Medicine Holdings' Other Financing of S$-4.28 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Singapore Institute Of Advanced Medicine Holdings and its competitors. Singapore Institute Of Advanced Medicine Holdings's current Other Financing is S$-4.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current Other Financing of S$-4.28 Mil. The current Other Financing is S$-4.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current Other Financing is S$-4.28 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Singapore Institute Of Advanced Medicine Holdings Business Description

Address 1 Biopolis Drive, No. 02-01 Amnios, Singapore, SGP, 138622
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.